Mikael Eriksson
11 – 20 of 155
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
- Contribution to journal › Article
-
Mark
Fibrinogen-like protein 2 in gastrointestinal stromal tumour
- Contribution to journal › Article
-
Mark
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes : Pooled Analysis of Population-Based Studies
- Contribution to journal › Article
- 2021
-
Mark
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy : Results from the EUROpean Bone Over 40 Sarcoma Study
- Contribution to journal › Article
-
Mark
Adjuvant imatinib for GIST : duration likely matters
- Contribution to journal › Debate/Note/Editorial
-
Mark
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
- Contribution to journal › Scientific review
-
Mark
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
- Contribution to journal › Article
-
Mark
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
- Contribution to journal › Article
- 2020
-
Mark
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic
- Contribution to journal › Article
-
Mark
Rare cancers of unknown etiology : lessons learned from a European multi-center case–control study
- Contribution to journal › Article
